Office-Based Addiction Treatment (OBAT)
To speak directly with one of our registered nurses please call (413) 325-8508.
This is a resource for both established patients and for new patients looking to become registered with CHCFC.
(Feel free to leave a confidential voicemail if we are away from our desks and we will call you back).
The Community Health Center of Franklin County follows a medication-first, patient-centered model of treating Substance Use Disorders. We offer a full spectrum of treatment options for Opioid Use Disorder, Alcohol Use Disorder, and Stimulant Use Disorder, including medication, counseling, and recovery support services with the goal of minimizing negative outcomes and supporting each patient where they are on the recovery spectrum.
We consider medications for substance use disorder to be a large part of treatment and the recovery process and we prescribe them with the intention of helping patients reduce use, decrease the risk of overdose, improve overall health outcomes, and preserve life.
Our medical providers and nurses also work closely with our Behavioral Health team, Recovery Coaches, and local service agencies to connect patients with ongoing recovery resources.
We understand that Substance Use Disorders can prevent patients from living their best lives and far too frequently cause unintentional harm and death. We are committed to providing low barrier care for these disorders and working with patients to build intentional, therapeutic relationships.
Our Office Based Addiction Treatment guidelines are a patient centered, nurse driven protocol designed to help patients meet their goals by supporting them throughout their recovery journey. We aim to be the hub of our patient's healthcare by connecting patients with resources from providers, inpatient treatment and other community resources.
SUBOXONE®
SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine used to treat patients aged 18 and older who are physically dependent on opioids as part of a complete treatment program that also includes counseling and behavioral therapy. Suboxone has been shown to reduce opioid overdoses, increase time in treatment, and improve odds for long term recovery.
SUBLOCADE
(Buprenorphine) Is a once-monthly injectable medication for treatment of moderate-severe OUD. Sublocade provides an injectable Buprenorphine option to be administered in office once monthly. Sublocade may provide a patient the freedom to step away from daily oral dosing of Suboxone. Patients are eligible to start Sublocade after 7 days of treatment with oral Buprenorphine.
BRIXADI
(Buprenorphine) Is another option for injectable Buprenorphine. Brixadi allows for both weekly and monthly dosing options. Patients may be eligible for Birxadi after tolerating a single dose of oral Buprenorphine. Brixadi is not suitable for patients with a latex allergy.
NALTREXONE
is a non-addictive prescription medication that can be taken as a daily oral tablet or can be administered as an injection in the office once a month (Vivitrol). Naltrexone is used to treat Alcohol Use Disorder and/or Opioid Use Disorder. Naltrexone can help to reduce cravings for both alcohol and opioids.
ACAMPROSATE
is a non-addictive prescription medication that is taken by mouth three times daily and can help to reduce cravings for alcohol. It can be used alone or in combination with another medication such as Naltrexone or Disulfiram.
DISULFIRAM
is a medication for patients with an alcohol use disorder who require or desire an enforced state of sobriety, which may allow for additional supportive and psychotherapeutic treatment.
Also Available:
Narcan
Fentanyl Test Strips
Xylazine Test Strips
To speak directly with one of our registered nurses please call (413) 325-8508.